中科電氣(300035.SZ):控股子公司獲得國際客户定點 將定點供應鋰離子電池負極材料產品
格隆匯2月23日丨中科電氣(300035.SZ)發佈公吿,公司控股子公司湖南中科星城石墨有限公司(以下簡稱“湖南中科星城”)於近日與海外某國際知名車企旗下電池子公司(以下簡稱“國際客户”)簽訂《Nomination Agreement》(《定點協議》,限於保密要求,無法披露國際客户名稱及協議具體條款),公司控股子公司將為該國際客户定點供應鋰離子電池負極材料產品。
本次獲得國際客户定點,是對公司負極材料產品性能和供貨資格的認可,亦是公司負極材料業務海外市場開拓的又一重大突破,將進一步提高公司海外市場佔比和國際化水平,有利於增強公司在新能源鋰離子電池負極材料領域的綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.